Arrowhead Pharmaceuticals Inc (ARWR)

46.21 -1.37  -2.88% NASDAQ Jan 23, 20:00 Delayed 2m USD
View Full Chart
Price Chart
View All Events

Events

Date Type Description
02/07/2020 16:30 EST Misc Arrowhead Pharmaceuticals Inc First Quarter Earnings Conference Call in 2020
02/07/2020 Earnings Arrowhead Pharmaceuticals Inc First Quarter Earnings in 2020 Release
11/25/2019 16:30 EST Misc Arrowhead Pharmaceuticals Inc Fourth Quarter Earnings Conference Call for 2019
11/25/2019 Earnings Arrowhead Pharmaceuticals Inc Fourth Quarter Earnings in 2019 Release
11/25/2019 Misc Arrowhead Pharmaceuticals Inc Annual Report for 2019
08/05/2019 16:30 EDT Misc Arrowhead Pharmaceuticals Inc Third Quarter Earnings Conference Call in 2019
08/05/2019 Earnings Arrowhead Pharmaceuticals Inc Third Quarter Earnings in 2019 Release
05/08/2019 16:30 EDT Misc Arrowhead Pharmaceuticals Inc Second Quarter Earnings Conference Call in 2019
05/08/2019 Earnings Arrowhead Pharmaceuticals Inc Second Quarter Earnings in 2019 Release
03/14/2019 10:00 PDT Misc Arrowhead Pharmaceuticals Inc Annual General Meeting in 2018
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • URL: https://www.arrowheadpharma.com
  • Investor Relations URL: http://ir.arrowheadpharma.com/
  • HQ State/Province: California
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Mid Cap/Growth
  • Next Earnings Release: Feb. 07, 2020
  • Last Earnings Release: Nov. 25, 2019
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A
  • Description: Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting hepatitis B, Alpha-1 Antitrypsin Deficiency, thrombosis and angioedema, clear-cell and renal cell carcinoma, and cardiovascular disease.

Top Fund Holders

Symbol Name Weighting
PTH Invesco DWA Healthcare Momentum ETF 2.97%
RFG Invesco S&P MidCap 400® Pure Growth ETF 1.66%
GOFFX Invesco Oppenheimer Global Opp R5 1.58%
DWAS Invesco DWA SmallCap Momentum ETF 1.36%
FBIOX Fidelity® Select Biotechnology 1.35%
DYN1528 Dynamic Power American Growth Series OP 0.93%
PSC Principal US Small Cap Mlt Fac Ind ETF 0.93%
PSAPX Principal SmallCap S&P 600 Index R1 0.89%
VTWG Vanguard Russell 2000 Growth ETF 0.54%
TRHBX TIAA-CREF Small-Cap Blend Idx Advisor 0.33%
SWSSX Schwab Small Cap Index 0.28%
VTWO Vanguard Russell 2000 ETF 0.28%

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.